NanaBis

delta9-Tetrahydrocannabinol (d9-THC) & Cannabidiol (CBD) · Medlab Clinical

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NanaBis, covering 2022-04-12 to 2022-04-12. Get the full timeline:

Most recent: Clinical Trial Update: NanaBis™ an Oro-buccal Administered delta9-Tetrahydrocannabinol (d9-THC) & Cannabidiol (CBD) Medicine for the Management of Bone Pain From Metastatic Cancers [Phase 3]

See pricing